Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 7—July 2022
Dispatch

Determining Infected Aortic Aneurysm Treatment Using Focused Detection of Helicobacter cinaedi

Saito JienComments to Author , Rimbara Emiko, Inaguma Shingo, Hasegawa Chihiro, Kamiya Shinji, Mizuno Akihiro, Sone Yoshiaki, Ogawa Tatsuhito, Numata Yukihide, Takahashi Satoru, and Asano Miki
Author affiliations: Nagoya City University East Medical Center, Aichi, Japan (S. Jien, I. Shingo, H. Chihiro, K. Shinji, M. Akihiro, S. Yoshiaki, O. Tatsuhito, N. Yukihide, A. Miki); National Institute of Infectious Diseases, Tokyo, Japan (R. Emiko); Nagoya City University, Aichi (T. Satoru)

Main Article

Table 2

Bacteriological examination, method of treatment, and outcomes for 10 patients with infected aortic aneurysms with or without Helicobacter cinaedi, Aichi, Japan, September 2017–January 2021*

Patient no. Age, y/sex Location Blood cultures ID Comorbidity Procedure‡ Antimicrobial
use period		 Outcome
H. cinaedi group, n = 4†
1 72/M Aortic arch 75.3/negative ST6 DM TAR (positive) 6 mo Survival at 4 y
2 64/F Right common iliac Negative Unknown DM Y graft (negative) 6 mo Survival at 3 y
3 83/M Infrarenal aorta 86.5/160.8 ST18 Malignant lymphoma EVAR (NA) 6 mo Survival at 2 y
4
 88/M
 Infrarenal aorta
 90.6/93.0
 ST21
 CKD
 Medical treatment only (NA)
 3 mo
 Survival at 1 y
Non–H. cinaedi group, n = 6§
1 70/M Infrarenal aorta Negative MSSA None Y graft 6 mo Survival at 4 y
2 74/M Infrarenal aorta Negative Listeria monocytogenes None Y graft 6 mo Survival at 4 y
3 67/M Infrarenal aorta 12.6/12.6 Enterobacter cloacae AEF Y graft 6 mo Survival at 3 y
4 83/M Infrarenal aorta 12.3/12.3 MSSA DM Y graft 3 mo Survival at 3 y
5 86/F Thoracoabdominal aorta Negative MSSA None Medical treatment only 3 mo Survival at 1 y
6 80/M Infrarenal aorta 28.3/28.3 Salmonella enteritidis None Y graft Until death Death at POD 5

*DM, diabetes mellitus; CKD, chronic kidney disease; TAR, total arch replacement; EVAR, endovascular aortic repair; NA, not applicable; MSSA, methicillin-susceptible Staphylococcus aureus; AEF, aorto-enteric fistula; POD, postoperative day; ST, sequence type. †16S RNA results were positive for all patients. ‡Y graft replacement for abdominal aortic aneurysm. §Tissue culture results for all patients returned in 1 d; patient 5 had an abscess.

Main Article

Page created: May 05, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external